sep 18, 2023 · gsk’s senior vice president and head of research john lepore, m. d. , has left the company at the same time the u. k. Pharma undergoes a slight shuffling of its r&d operations. feb 2, 2023 · gsk chief executive officer emma walmsley warned the u. k. Is at a “tipping point” and risks falling short of government ambitions to become a life sciences. sep 9, 2024 · pharmaceutical firm glaxosmithkline (gsk) has confirmed job losses at one of its uk sites. It is believed about 200 roles will be cut at the facility in barnard castle,. The acquisition closed in june 2023 and centered around a p2x3.
